Published in Psychol Med on January 04, 2007
The feasibility and validity of ambulatory self-report of psychotic symptoms using a smartphone software application. BMC Psychiatry (2012) 1.58
Ambulatory assessment. Annu Rev Clin Psychol (2012) 1.56
Cascades of Emotion: The Emergence of Borderline Personality Disorder from Emotional and Behavioral Dysregulation. Rev Gen Psychol (2009) 1.29
The everyday emotional experience of adults with major depressive disorder: Examining emotional instability, inertia, and reactivity. J Abnorm Psychol (2012) 1.24
A comparison of retrospective self-report versus ecological momentary assessment measures of affective lability in the examination of its relationship with bulimic symptomatology. Behav Res Ther (2010) 1.14
Components of emotion dysregulation in borderline personality disorder: a review. Curr Psychiatry Rep (2013) 1.10
Qualitative and quantitative distinctions in personality disorder. J Pers Assess (2011) 1.07
Interpersonal and emotional experiences of social interactions in borderline personality disorder. J Nerv Ment Dis (2009) 1.01
Specificity of affective instability in patients with borderline personality disorder compared to posttraumatic stress disorder, bulimia nervosa, and healthy controls. J Abnorm Psychol (2014) 0.96
Anger, preoccupied attachment, and domain disorganization in borderline personality disorder. J Pers Disord (2009) 0.94
Mood as Representation of Momentum. Trends Cogn Sci (2015) 0.91
Borderline personality pathology and the stability of interpersonal problems. J Abnorm Psychol (2013) 0.89
Conceptualizing and Estimating Process Speed in Studies Employing Ecological Momentary Assessment Designs: A Multilevel Variance Decomposition Approach. Multivariate Behav Res (2011) 0.87
Mental state decoding abilities in young adults with borderline personality disorder traits. Personal Disord (2011) 0.85
On the temporal characteristics of performance variability in attention deficit hyperactivity disorder (ADHD). PLoS One (2013) 0.85
Negative Affect Instability among Individuals with Comorbid Borderline Personality Disorder and Posttraumatic Stress Disorder. Clin Psychol Sci (2015) 0.84
Affective and Self-Esteem Instability in the Daily Lives of People with Generalized Social Anxiety Disorder. Clin Psychol Sci (2014) 0.83
Modeling Heterogeneity in Momentary Interpersonal and Affective Dynamic Processes in Borderline Personality Disorder. Assessment (2016) 0.81
Using Negative Emotions to Trace the Experience of Borderline Personality Pathology: Interconnected Relationships Revealed in an Experience Sampling Study. J Pers Disord (2015) 0.81
Non-suicidal self-injury and emotion regulation: a review on facial emotion recognition and facial mimicry. Child Adolesc Psychiatry Ment Health (2013) 0.80
Affective Dynamics in Psychopathology. Emot Rev (2015) 0.80
Examining the Dynamic Structure of Daily Internalizing and Externalizing Behavior at Multiple Levels of Analysis. Front Psychol (2015) 0.79
The specificity of emotional switching in borderline personality disorder in comparison to other clinical groups. Personal Disord (2016) 0.79
Emotional lability and affective synchrony in borderline personality disorder. Personal Disord (2016) 0.78
Personality Pathology and Interpersonal Problem Stability. J Pers Disord (2015) 0.78
Ecological Momentary Assessment of Affective and Interpersonal Instability in Adolescent Non-Suicidal Self-Injury. J Abnorm Child Psychol (2016) 0.76
Momentary symptoms of borderline personality disorder as a product of trait personality and social context. Personal Disord (2016) 0.76
Daily Interpersonal and Affective Dynamics in Personality Disorder. J Pers Disord (2015) 0.76
A comprehensive examination of delayed emotional recovery in borderline personality disorder. J Behav Ther Exp Psychiatry (2014) 0.76
A perfect storm: examining the synergistic effects of negative and positive emotional instability on promoting weight loss activities in anorexia nervosa. Front Psychol (2015) 0.75
The current state and future of factor analysis in personality disorder research. Personal Disord (2017) 0.75
Hyper-modulation of brain networks by the amygdala among women with Borderline Personality Disorder: Network signatures of affective interference during cognitive processing. J Psychiatr Res (2016) 0.75
Moods in Clinical Depression Are More Unstable than Severe Normal Sadness. Front Psychiatry (2017) 0.75
Fragile and Enduring Positive Affect: Implications for Adaptive Aging. Gerontology (2016) 0.75
Interpersonal problems and negative affect in Borderline Personality and Depressive Disorders in daily life. Clin Psychol Sci (2017) 0.75
The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials. Dtsch Arztebl Int (2010) 3.67
The financing of drug trials by pharmaceutical companies and its consequences: part 2: a qualitative, systematic review of the literature on possible influences on authorship, access to trial data, and trial registration and publication. Dtsch Arztebl Int (2010) 3.36
Borderline personality disorder. Lancet (2004) 3.32
What users think about the differences between caffeine and illicit/prescription stimulants for cognitive enhancement. PLoS One (2012) 2.44
Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev (2012) 2.43
Impact of co-occurring posttraumatic stress disorder on suicidal women with borderline personality disorder. Am J Psychiatry (2010) 2.33
Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial. Ann Intern Med (2012) 2.14
Reasons for suicide attempts and nonsuicidal self-injury in women with borderline personality disorder. J Abnorm Psychol (2002) 2.00
A biosocial developmental model of borderline personality: Elaborating and extending Linehan's theory. Psychol Bull (2009) 2.00
Psychosocial intervention development for the prevention and treatment of depression: promoting innovation and increasing access. Biol Psychiatry (2002) 1.99
A pilot study of the DBT coach: an interactive mobile phone application for individuals with borderline personality disorder and substance use disorder. Behav Ther (2011) 1.81
Neural correlates of antinociception in borderline personality disorder. Arch Gen Psychiatry (2006) 1.78
Analytic strategies for understanding affective (in)stability and other dynamic processes in psychopathology. J Abnorm Psychol (2009) 1.69
Declaration and Handling of Conflicts of Interest in Guidelines: A Study of S1 Guidelines From German Specialist Societies From 2010-2013. Dtsch Arztebl Int (2015) 1.68
Dialectical behavior therapy for substance abusers. Addict Sci Clin Pract (2008) 1.67
Differentiation of pain ratings in combat-related posttraumatic stress disorder. Pain (2009) 1.60
Dialectical behavior therapy for borderline personality disorder. Annu Rev Clin Psychol (2007) 1.55
The place of additional individual psychotherapy in the treatment of alcoholism: a randomized controlled study in nonresponders to anticraving medication-results of the PREDICT study. Alcohol Clin Exp Res (2013) 1.52
Syndromes and phenomenological subtypes underlying acute mania: a factor analytic study of 576 manic patients. Am J Psychiatry (2002) 1.51
An intensive treatment program of interpersonal psychotherapy plus pharmacotherapy for depressed inpatients: acute and long-term results. Am J Psychiatry (2007) 1.50
Change in suicide rates in Switzerland before and after firearm restriction resulting from the 2003 “Army XXI” reform. Am J Psychiatry (2013) 1.50
Frontolimbic brain abnormalities in patients with borderline personality disorder: a volumetric magnetic resonance imaging study. Biol Psychiatry (2003) 1.48
Suicide assisted by right-to-die associations: a population based cohort study. Int J Epidemiol (2014) 1.48
Self-stigma, empowerment, and perceived legitimacy of discrimination among women with mental illness. Psychiatr Serv (2006) 1.48
Validation of the Spanish version of the Borderline Symptom List, short form (BSL-23). BMC Psychiatry (2013) 1.45
Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study. Br J Psychiatry (2008) 1.40
Self-stigma in women with borderline personality disorder and women with social phobia. J Nerv Ment Dis (2006) 1.39
Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom (2013) 1.38
Randomized response estimates for the 12-month prevalence of cognitive-enhancing drug use in university students. Pharmacotherapy (2013) 1.32
Use of illicit and prescription drugs for cognitive or mood enhancement among surgeons. BMC Med (2013) 1.31
Interferon alpha (IFNalpha) and psychiatric syndromes: a review. Prog Neuropsychopharmacol Biol Psychiatry (2002) 1.28
The short version of the Borderline Symptom List (BSL-23): development and initial data on psychometric properties. Psychopathology (2008) 1.28
Increased nocturnal interleukin-6 excretion in patients with primary insomnia: a pilot study. Brain Behav Immun (2005) 1.26
Effects of a partly self-administered exercise program before, during, and after allogeneic stem cell transplantation. Blood (2010) 1.24
Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study. Addict Biol (2012) 1.24
Dialectical behavior therapy for posttraumatic stress disorder related to childhood sexual abuse: a pilot study of an intensive residential treatment program. J Trauma Stress (2011) 1.23
Shame and implicit self-concept in women with borderline personality disorder. Am J Psychiatry (2007) 1.22
Signal transduction pathways regulating cyclooxygenase-2 in lipopolysaccharide-activated primary rat microglia. Glia (2005) 1.22
Altered pain processing in veterans with posttraumatic stress disorder. Arch Gen Psychiatry (2007) 1.22
Mechanisms of change in dialectical behavior therapy: theoretical and empirical observations. J Clin Psychol (2006) 1.20
Effectiveness of inpatient dialectical behavioral therapy for borderline personality disorder: a controlled trial. Behav Res Ther (2004) 1.19
Emotional modulation of pain: a clinical perspective. Pain (2006) 1.18
Pharmacological interventions for borderline personality disorder. Cochrane Database Syst Rev (2010) 1.18
Psychosocial treatments of suicidal behaviors: a practice-friendly review. J Clin Psychol (2006) 1.17
Gender differences in axis I and axis II comorbidity in patients with borderline personality disorder. Psychopathology (2009) 1.16
SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging. Neuroimage (2008) 1.16
Euthanasia and assisted suicide in selected European countries and US states: systematic literature review. Med Care (2013) 1.15
Affective dysregulation and dissociative experience in female patients with borderline personality disorder: a startle response study. J Psychiatr Res (2005) 1.15
Motives for nonsuicidal self-injury among women with borderline personality disorder. J Nerv Ment Dis (2008) 1.14
Sexually transmitted disease rates and high-risk sexual behaviors in borderline personality disorder versus borderline personality disorder with substance use disorder. J Nerv Ment Dis (2007) 1.14
A valence-dependent group-specific recall bias of retrospective self-reports: a study of borderline personality disorder in everyday life. J Nerv Ment Dis (2006) 1.13
Treating co-occurring Axis I disorders in recurrently suicidal women with borderline personality disorder: a 2-year randomized trial of dialectical behavior therapy versus community treatment by experts. J Consult Clin Psychol (2008) 1.12
Disentangling emotion processes in borderline personality disorder: physiological and self-reported assessment of biological vulnerability, baseline intensity, and reactivity to emotionally evocative stimuli. J Abnorm Psychol (2009) 1.12
Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential. CNS Drugs (2005) 1.12
Reliability of three alternate forms of the trail making tests a and B. Arch Clin Neuropsychol (2011) 1.11
Inhibition of LPS-induced p42/44 MAP kinase activation and iNOS/NO synthesis by parthenolide in rat primary microglial cells. J Neuroimmunol (2002) 1.09
Attention-deficit hyperactivity disorder as a potentially aggravating factor in borderline personality disorder. Br J Psychiatry (2008) 1.09
Cost-effective primary care-based strategies to improve smoking cessation: more value for money. Arch Intern Med (2009) 1.09
Affect regulation and pain in borderline personality disorder: a possible link to the understanding of self-injury. Biol Psychiatry (2010) 1.08
Deep brain stimulation for treatment of refractory depression. Lancet (2005) 1.06
Ecological momentary assessment in borderline personality disorder: a review of recent findings and methodological challenges. J Pers Disord (2012) 1.05
Emotional responses to self-injury imagery among adults with borderline personality disorder. J Consult Clin Psychol (2008) 1.04
Dialectical behavior therapy skills use as a mediator and outcome of treatment for borderline personality disorder. Behav Res Ther (2010) 1.04
Elevated pain thresholds correlate with dissociation and aversive arousal in patients with borderline personality disorder. Psychiatry Res (2006) 1.04
Increased delta power and discrepancies in objective and subjective sleep measurements in borderline personality disorder. J Psychiatr Res (2005) 1.02
Treating PTSD in suicidal and self-injuring women with borderline personality disorder: development and preliminary evaluation of a Dialectical Behavior Therapy Prolonged Exposure Protocol. Behav Res Ther (2012) 1.02
Correlation of glutamate levels in the anterior cingulate cortex with self-reported impulsivity in patients with borderline personality disorder and healthy controls. Arch Gen Psychiatry (2010) 1.01
Cost of treatment of schizophrenia in six European countries. Schizophr Res (2009) 1.01
Measuring shame and guilt by self-report questionnaires: a validation study. Psychiatry Res (2007) 1.01
Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression. Neuropharmacology (2011) 1.00
Emotional learning during dissociative states in borderline personality disorder. J Psychiatry Neurosci (2009) 1.00
Psychophysiological ambulatory assessment of affective dysregulation in borderline personality disorder. Psychiatry Res (2007) 1.00
Pain sensitivity and neural processing during dissociative states in patients with borderline personality disorder with and without comorbid posttraumatic stress disorder: a pilot study. J Psychiatry Neurosci (2010) 1.00
Differentiating adolescent self-injury from adolescent depression: possible implications for borderline personality development. J Abnorm Child Psychol (2012) 1.00
Regulation of prostaglandin E2 synthase expression in activated primary rat microglia: evidence for uncoupled regulation of mPGES-1 and COX-2. Glia (2008) 1.00
Salivary cortisol, heart rate, electrodermal activity and subjective stress responses to the Mannheim Multicomponent Stress Test (MMST). Psychiatry Res (2012) 0.99